MCRB, US81750R2013

Seres Therapeutics stock quoted at EUR 1.74 late on October 29

Published on 10/30/2026 at 02:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Seres Therapeutics has an upcoming results date listed for November 4. The company trades under MCRB and is identified by ISIN US81750R2013.

Quote and upcoming company update

The late quote is a dated Lang & Schwarz snapshot rather than a verified Xetra closing price.
Seres Therapeutics is identified by ticker MCRB and ISIN US81750R2013.

MCRB, US81750R2013, Illustration mit AI erstellt.

Seres Therapeutics stock was quoted at 1.74 euros in a late Lang & Schwarz snapshot dated October 29, 2026. The record was timestamped 22:59:30 Berlin time and showed a bid of 1.73 euros and an ask of 1.75 euros.

Late quote sets the reference point

The quote provides a current reference for the security identified by ISIN US81750R2013. Its timestamp is from the previous evening, so it should not be presented as an intraday quote for October 30.

The displayed previous close was also 1.74 euros. Because this is a Lang & Schwarz data point and not a verified Xetra close, no Xetra-based daily percentage change is assigned here.

Investor context remains date-sensitive

The company is listed under the ticker MCRB. Investors should distinguish the dated quote from company announcements and financial reporting dates, which refer to separate events and may affect the security at different times.

For a direct view of the security, see the real-time quote of Seres Therapeutics stock.

Broader US equity sentiment can be followed through the S&P 500 market overview.

For company-specific coverage, see More news and analyses on Seres Therapeutics stock.